<- Go Home

Paxman AB (publ)

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.

Market Cap

SEK 1.7B

Volume

33.8K

Cash and Equivalents

SEK 152.7M

EBITDA

SEK 48.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 179.5M

Profit Margin

65.96%

52 Week High

SEK 85.80

52 Week Low

SEK 44.00

Dividend

N/A

Price / Book Value

6.26

Price / Earnings

73.55

Price / Tangible Book Value

7.26

Enterprise Value

SEK 1.6B

Enterprise Value / EBITDA

32.75

Operating Income

SEK 32.3M

Return on Equity

10.48%

Return on Assets

7.99

Cash and Short Term Investments

SEK 152.7M

Debt

SEK 9.5M

Equity

SEK 276.0M

Revenue

SEK 272.1M

Unlevered FCF

SEK 10.5M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches